Vaccination against COVID-19 for adolescents 12 to 17 years – Covid Vaccine

The time has come to vaccinate adolescents against COVID-19, especially those with risk comorbidities (diseases that they already have and that weaken their immune system), as well as pregnant adolescents from the ninth week.

Adolescents with diseases that weaken their immune systems are more vulnerable to COVID-19 that can present serious complications that warrant hospitalization, admission to intensive care units, the need for mechanical ventilation or conditions that increase the risk of dying.

For this reason, it is important that they get vaccinated and that in addition to the vaccine, they follow hygiene measures, healthy distance and use the mask correctly to protect their health.

Vaccine safety and efficacy

The vaccine to be applied is the Pfizer-Biontech, which showed safety and efficacy results of 75% after the 1st dose and 95% 7 days after the 2nd dose.

The following table describes the diseases or risk factors that will be considered:

  • Congenital or acquired heart disease with heart failure data
  • Hypertension artrial primary or secondary in medical treatment with anti-hypertensive drugs.
  • Severe poorly controlled asthma: use of high-dose inhaled steroids along with a second controller medication in addition to at least one of the following: a) use of 3 or more cycles of systemic steroid in the previous year due to asthma exacerbations, or b) one or more asthma hospitalizations in the previous year (patients with adequate inhaler-based control did not are eligible in this group).
  • Ciliary dyskinesias.
  • Bronchopulmonary dysplasia.
  • Cystic fibrosis.
  • Interstitial pulmonary fibrosis.
  • Congenital malformations of the respiratory system
  • Congenital malformations of the kidney, liver or digestive system that conditions a risk for life.
  • Severe gastroesophageal reflux that can predispose to respiratory infections.
  • Gastrostomy patients.
  • Cirrhosis.
  • Billiard atresia.
  • Chronic hepatitis
  • Chronic renal failure grade 3 or higher including patients with replacement therapy (hemodialysis or peritoneal dialysis)
  • Neurodisability and / or neuromuscular disease including cerebral palsy, moderate or severe autism, hard-to-control epilepsy with neurological impairment, and muscular dystrophy.
  • Congenital disorders that can affect the nervous system.
  • Hereditary and degenerative disease of the nervous system or muscles or other conditions associated with hypoventilation.
  • Multiple or severe or profound learning disabilities (PMLD).
  • Myasthenia and related diseases.
  • Multiple sclerosis
  • Down syndrome.
  • Diabetes mellitus in any of its forms and degree of control.
  • Addison’s syndrome.
  • Hypopituitary syndrome.
  • Severe obesity (equal to or greater than 3 standard deviations (SD) of the 2007 WHO reference tables (see categories in annex)
  • Active treatment for solid tumors or hematologic malignancies (leukemia, lymphoma, and myeloma), or within 3 years of healing.
  • Solid organ or stem cell transplant recipients within 2 years of transplantation or receiving immunosuppressive treatment).
  • On the waiting list for transplantation.
  • Moderate or severe primary immunodeficiency (eg, DiGeorge syndrome, Wiskott-Aldrich syndrome, Common Variable Immunodeficiency) or secondary to disease / treatment.
  • Active treatment with immunosuppressants that produce significant immunosuppression (including high-dose corticosteroids (adolescents and children> 10 kg: prednisone ≥20 mg or its equivalent per day when administered for ≥2 weeks), alkylating agents, antimetabolites, immunosuppressive drugs related to transplantation, cancer chemotherapeutic agents, tumor necrosis factor (TNF) blockers and other drugs that are significantly immunosuppressive or have received them in the previous 6 months, immunosuppressive chemotherapy or radiation therapy.
  • Autoimmune diseases that may require long-term immunosuppressive treatments, systemic lupus erythematosus and rheumatoid arthritis, among others.
  • HIV / AIDS infection.
  • Tuberculosis Infections.
  • Hereditary spherocytosis.
  • Homozygous sickle cell disease.
  • Thalassemia major.
  • Any other case of cause of asplenia.
  • Hemophilia
  • Mitochondrial diseases.
  • Chromosomal abnormalities.
  • Lysosomal diseases.
  • Inborn errors of metabolism
  • From 9 weeks of pregnancy


How do vaccines work?
Recommendations for before and after the application of the vaccine
Symptoms that may occur after the application of the vaccine


How do vaccines work?
Pfizer vaccine characteristics
Can I get it even when I’m vaccinated?

You need to pre-register from October 1, 2021 on the page in which you must have at hand, the CURP of your sons or daughters, contact information such as: data of the minor and of the father, mother or guardian, telephone and email.

In this registry, you must select the risk or comorbidity group to which your son or daughter belongs, according to their clinical diagnosis, in addition to indicating the institution, care unit or particular service where they are treated.

Remember that after pre-registration they will contact you to indicate the day, time and place where you will receive the vaccine.

When attending your vaccination appointment remember:

  • Show up with your son or daughter on the corresponding date, time and unit, with the printed receipt,
  • Present the card and / or proof that certifies the diagnosis of one of the risk diseases, issued by the treating physician
  • Follow the instructions of the staff of the brigades
  • Carry out prevention and hygiene measures.

The post Vaccination against COVID-19 for adolescents 12 to 17 years – Covid Vaccine appeared first on World Today News.

Source link

Leave a Comment